02.02.2006 21:08:00
|
IMS Health to Host 2006 Investor Day on February 13 at 9:00 a.m. EST
Investors are invited to listen to the sessions via teleconferenceor live Webcast. The dial-in numbers for the conference call are:
-- U.S. and Canadian participants: 1-888-313-7737
-- International participants: 1-212-676-5255
An audio replay of the conference call will be available beginningat 2:30 p.m. EST on February 13, 2006 and extend through February 20.The replay dial-in numbers are:
-- U.S. and Canadian participants: 1-800-633-8284
-- International participants: 1-402-977-9140
Reservation # 21282154
To listen to a live Webcast of the IMS presentations and to viewaccompanying slides, go tohttp://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=67124&eventID=1200961 (Due to its length, this URL may need to becopied/pasted into your Internet browser's address field. Remove theextra space if one exists.) or to the "Investors" area of the IMSwebsite at http://www.imshealth.com.
For additional details and registration information, contact TammyTobin by e-mail at RX_InvestorDay2006@imshealth.com or by phone at(203) 319-4761.
About IMS
Operating in more than 100 countries, IMS Health is the world'sleading provider of market intelligence to the pharmaceutical andhealthcare industries. With $1.8 billion in 2005 revenue and more than50 years of industry experience, IMS offers leading-edge businessintelligence products and services that are integral to clients'day-to-day operations, including portfolio optimization capabilities;launch and brand management solutions; sales force effectivenessinnovations; managed care and over-the-counter offerings; andconsulting and services solutions that improve ROI and the delivery ofquality healthcare worldwide. Additional information is available athttp://www.imshealth.com.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu IMS Health Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu IMS Health Inc.mehr Analysen
Indizes in diesem Artikel
S&P 500 | 5 918,25 | 0,16% | |
FTSE GLOB TECH | 1 498,45 | -3,25% |